Psychopharmacology
Looking for contact hours in pharmacology? These podcasts, recorded from recent live conferences, provide cutting-edge clinical updates and are eligible for psychopharmacology contact hours.
2011-19: Ketamine Treatment: Promise for the Future and How Nurses Impact Care
Contains 5 Component(s), Includes CreditsPresenters: Paula S. Bolton, MS, CNP, ANP-BC; Courtney Miller, RN 0.75 pharmacology contact hours
2041-19: Pharmacogenomics and Psychiatry: Current Trends and Practical Experience
Contains 5 Component(s), Includes CreditsPresenter: Jessica Whelan, FPMHNP-BC, RN, BSN, MSN, FMHNP 0.5 pharmacology contact hours
2051-19: The Art of Polypharmacy: There’s a Pill for That
Contains 5 Component(s), Includes CreditsPresenter: Melissa Whitesell, MS, CPNP-AC, FNP-BC, PMHS-BC 0.75 pharmacology contact hours
2021-19: Exploring the Potential Use of Psychedelics for the Improvement of Persistent and Intractable Mental Health Symptoms
Contains 5 Component(s), Includes CreditsPresenter: Carlton J. Spotswood, BSN, RN-BC, PMHNP-S 0.75 pharmacology contact hours
1031-19: When Less is More: Deprescribing in PMHNP Practice
Contains 5 Component(s), Includes CreditsPresenters: Lyons Hardy, PMHNP; Kirby Williams, MSN, PMHNP 1.5 pharmacology contact hours
1021-19: Integrating Brief Cognitive Behavioral Therapy (CBT) into Medication Management Visits: Advanced Practice PMH Nurses Leveraging their Psychotherapy Skills as well as their Knowledge of Pharmacology in 20-30 Minute Visits to Optimize Outcomes
Contains 5 Component(s), Includes CreditsPresenters: Pamela Lusk, RN, DNP, PMHNP-BC, FAANP; Bernadette Mazurek Melnyk, PhD, RN, PMHNP-BC, CPNP, FAAN, FAANP 1.75 pharmacology contact hours
3021-19: Adolescent Pregnancy and Depression: An Opportunity and Obligation for Intervention
Contains 5 Component(s), Includes CreditsPresenter: Sarah Cox, MSN, PMHNP-BC 0.5 pharmacology contact hours
3011-19: Mini Concurrent Sessions: Pharmacology
Contains 6 Component(s), Includes CreditsPresenters: Evelyn J. Norton, APN, DNP, PMHNP-BC; Claire E. Oliver, MSN, PMHNP-BC; Kristin E. Katsenes, RN, BSN, PEL-CSN (IL); Joanne DeSanto Iennaco, PhD 0.5 pharmacology contact hours
303-19: Pharmacological Management of Alzheimer’s Disease and Other Neurocognitive Disorders
Contains 5 Component(s), Includes CreditsPresenter: Pamela Z. Cacchione, PhD, CRNP, BC, FGSA, FAAN 1.5 pharmacology contact hours
301-19: From Immediate Release to Long Acting: Drug Delivery Systems - What Do They Mean & Why Do They Matter?
Contains 5 Component(s), Includes CreditsPresenter: Laura G. Leahy, DrNP, APRN, FAANP 1.5 pharmacology contact hours
304-19: Neurobiologic Aspects of Trauma
Contains 5 Component(s), Includes CreditsPresenter: Elizabeth M. Fitelson, M.D. 1.5 pharmacology contact hours
302-19: Gabapentin Use & Misuse
Contains 5 Component(s), Includes CreditsPresenter: Christian J. Teter, PharmD, BCPP, RPh 1.25 pharmacology contact hours
202-19: Complex Topics in Substance Use: Drug Adulterants, Treatment Transitions, & Pregnancy
Contains 5 Component(s), Includes CreditsPresenter: Matt Tierney, ANP, PMHNP, FAAN 1.5 pharmacology contact hours
203-19: The Art of Deprescribing: An Evidence-Based Approach to Understanding Who is the Right Patient, When is the Right Time, and How to Taper Medication?
Contains 5 Component(s), Includes CreditsPresenter: Dawn Vanderhoef, PhD, DNP, PMHNP-BC, FAANP 1.5 pharmacology contact hours
W102-19: Psychopharmacology for Persons with Alzheimer's and Other Dementias
Contains 5 Component(s), Includes CreditsPresenter: Pierre Tariot, MD 1.5 pharmacology contact hours
W103-19: Ethical Decision-Making in Mental Health & Psychopharmacology
Contains 5 Component(s), Includes CreditsPresenters: Mindy B. Zeitzer, PhD, MBE, RN; Barbara Limandri, PhD, PMHCNS-BC; Barbara Warren, PhD, RN, PMHCNS-BC, FNAP, FAAN 1.25 contact hours
3011-18: Mini Concurrent Sessions: Pharmacology
Contains 5 Component(s), Includes CreditsPresenters: Tammie Gainey, PhD, APRN, FNP-BC, PMHNP-BC; Steven L. Baumann, APRN, NP 0.5 pharmacology contact hours
2011-18: When the Medication Rules Don't Fit: Minimizing Delirium Risk for Older Adults in Integrated Primary Care
Contains 5 Component(s), Includes CreditsPresenter: Pamela R. Stover, DNP, ARNP, PMHNP-BC 0.75 contact hours (0.5 in pharmacology)
2021-18: Breaking Down Barriers: Increasing Access to Psychiatric Medications
Contains 5 Component(s), Includes CreditsPresenter: Judy A. Rice, DNP, PMHNP-BC, FNP-BC 0.75 pharmacology contact hours
2031-18: From Immediate Release to Long Acting, Drug Delivery Systems: What Do They Mean & Why Do They Matter?
Contains 5 Component(s), Includes CreditsPresenter: Laura G. Leahy, DrNP, APRN, PMH-CNS/FNP, CARN-AP, FAANP 0.5 pharmacology contact hours
1031-18: Mind and Body: Psychotropic Effects on Physiologic Health
Contains 5 Component(s), Includes CreditsPresenter: Alan Tony Amberg, APN, PMHNP-BC 2.0 pharmacology contact hours
1035-18: Trauma-Based Disorders and the Cardio-Neural Mechanisms Involved in Dysfunctional Self-Regulation
Contains 5 Component(s), Includes CreditsPresenters: William Nicholson, MSN, PMHNP-BC, PhD(c); Simone Durand, MSN, PMHNP-BC; Jennifer Carpenter, MSN, PMHNP-BC 2.0 contact hours (0.5 in pharmacology hours)
1041-18: Barriers to the Implementation of Pharmacogenomics in Psychiatric Clinical Practice: An Integrative Review
Contains 5 Component(s), Includes CreditsPresenter: David Nana Ampong, MSN, RN 1.0 pharmacology contact hours
301-18: Naming, Framing, and Containing the Physiology of Fear – A Wellness Approach
Contains 5 Component(s), Includes CreditsPresenter: Mary D. Moller, DNP, PhD, ARNP, PMHCNS-BC, CPRP, FAAN - 1.25 pharmacology contact hours
302-18: Psychotropic Medications & Impact on the Bone
Contains 5 Component(s), Includes CreditsPresenter: Karen L. Houseknecht, PhD - 1.0 pharmacology contact hours
204-18: Shared Decision Making in Pharmacotherapy Management
Contains 5 Component(s), Includes CreditsPresenter: Mary A. Gutierrez, PharmD, BCPP - 1.75 pharmacology contact hours
104-18: Legal Issues in Prescribing
Contains 5 Component(s), Includes CreditsPresenter: Carolyn Buppert, MSN, JD - 1.50 pharmacology contact hours
101-18: Marijuana Science Update
Contains 5 Component(s), Includes CreditsPresenter: Wilson M. Compton, MD, MPE - 1.50 pharmacology contact hours
2019 Effective Treatments for Opioid Use Disorder: Educating & Empowering Advanced Practice Registered Nurses (APRN) During an Epidemic
Contains 15 Component(s), Includes CreditsThis continuing educational activity was developed by the American Psychiatric Nurses Association to provide education to all nurses regarding the epidemic of opioid use in the U.S. and to answer the question, “What can nurses do?” to address this growing problem. Almost 4 million nurses can make a difference!
3022-17: Essential RN Competencies for the Induction and Maintenance of Opioid Replacement Therapy
Contains 5 Component(s), Includes CreditsPresenters: Janet Marie Standard, DNP, PMHNP-BC; Michelle Knapp, DNP, PMHNP-BC 0.75 pharmacology contact hours
2011-17: VA/DoD Clinical Practice Guideline for Opioid Therapy for Chronic Pain
Contains 5 Component(s), Includes CreditsPresenter: James Sall, PhD, FNP-BC 0.75 pharmacology contact hours
2031-17: So Many Atypical Antipsychotics How to Choose: The Current Psychopharmacological Treatment Landscape for Psychotic Spectrum Disorders
Contains 5 Component(s), Includes CreditsPresenter: Dawn Vanderhoef, PhD, DNP, PMHNP-BC, FAANP 0.75 pharmacology contact hours
2051-17: Mini Concurrent Sessions: Psychopharmacology
Contains 5 Component(s), Includes CreditsPresenters: Deborah Salani DNP, PMHNP-BC, NE-BC; Leigh A. Minchew DNP, APRN, WHNP-BC 0.75 pharmacology CE
1037-17: The Match Game: Matching Antidepressants to Symptoms of Anxiety and Depression--Which Drug for Which Symptom?
Contains 5 Component(s), Includes CreditsPresenter: Mary D. Moller DNP, ARNP, PMHCNS-BC, CPRP, FAAN 2.0 pharmacology contact hours
1027-17: Treating Tobacco & Nicotine Dependence: How Your Assumptions About Treatment Can Undermine Your Delivery of Care
Contains 5 Component(s), Includes CreditsPresenter: Carol Essenmacher PMHCNS-BC, DNP, CTTS 2.0 pharmacology contact hours
4011-17: An Introduction to Medication Assisted Treatments for Opiate Use Disorders
Contains 5 Component(s), Includes CreditsPresenter: Mary Weber, PhD, PMHNP-BC, FAANP, FAAN 0.75 pharmacology contact hours
100-18: Paradigm Shift in Treating Mental Illness: Neurophysiological Approach to Prescribing
Contains 5 Component(s), Includes CreditsPresenter: Barbara J. Limandri, PhD, PMHCNS-BC - 1.50 pharmacology contact hours
102-18: Microbiome, Gut, Hormones, Brain Connections in Mental Health/Addictions
Contains 5 Component(s), Includes CreditsPresenters: Wendy A. Henderson, PhD, MSN, CRNP, FAAN; Lorenzo Leggio, MD, PhD, MSc - 1.75 pharmacology contact hours
105-18: What’s Old Could Be New Again: Recognizing the Benefits and Neuroprotective Effects of Lithium
Contains 5 Component(s), Includes CreditsPresenter: Mary Ann Nihart, MA, APRN, PMHCNS-BC, PMHNP-BC 1.25 pharmacology contact hours
201-19: Managing Pharmacologic Treatment for Older Adults: Benzodiazepines and Antipsychotics
Contains 5 Component(s), Includes CreditsPresenter: Elizabeth Galik, PhD, CRNP, FAAN, FAANP 1.5 pharmacology contact hours
100-19: Deep Dive into Neurotransmitters: Focus on Glutamate and Gaba
Contains 5 Component(s), Includes CreditsPresenter: Debbie Thomas, Edd, APRN, PMHNP-BC, PMHCNS-BC, CMP 1.5 pharmacology contact hours
101-19: New Evidence, New Delivery Methods, New Opportunities for Engaging Clients
Contains 5 Component(s), Includes CreditsPresenter: Rebecca S. Roma MD, MBA 1.5 pharmacology contact hours
102-19: Complex Issues in Pediatric Psychopharmacology: Depressive & Anxiety Disorders
Contains 5 Component(s), Includes CreditsPresenter: Jeffrey R. Strawn, MD, FAACAP 1.5 pharmacology contact hours
104-19: Sexuality and Psychotropics
Contains 5 Component(s), Includes CreditsPresenter: Sattaria Dilks, DNP, APRN, PMHNP-BC 1.5 pharmacology contact hours
105-19: Ethical Considerations in Psychopharmacology
Contains 5 Component(s), Includes CreditsPresenters: Douglas P. Olsen, PhD, RN; Barbara Limandri, PhD, PMHCNS-BC; Barbara Jones Warren, PhD, RN, PMHCNS-BC, FNAP, FAAN 1.5 pharmacology contact hours
106-19: 2019 CPI Friday Outcomes Panel
Contains 5 Component(s), Includes CreditsPresenters: Barbara J. Limandri, PhD, PMHCNS-BC; Mary Ann Nihart, MA, APRN, PMHCNS-BC, PMHNP-BC; Brittany Yates, DNP, APRN, PMHNP-BC; Nick Guenzel, PhD, APRN-NP 0.5 pharmacology contact hours
1015-17: Treating Nicotine and Tobacco Dependence: Assumptions That Could be Harmful to Your Patients
Contains 5 Component(s), Includes CreditsPresenter: Carol Essenmacher, PMHCNS-BC, DNP, CTTS 1.25 pharmacology contact hours
1011-17: Optimizing the Aging Journey: Psychopharmacologic Approaches to Geriatric Anxiety, Depression, Delirium and Dementia
Contains 5 Component(s), Includes CreditsPresenter: Grace Nadolny, MD 1.5 pharmacology contact hours
1008-17: The Management of Mood and Anxiety Disorders in Pregnancy and Postpartum
Contains 5 Component(s), Includes CreditsPresenter: Lauren M. Osborne, MD 1.5 pharmacology contact hours
1010-17: Employing Multiple Mechanisms with Downstream Effects: Contemporary Psychopharmacologic Approaches
Contains 5 Component(s), Includes CreditsPresenter: Christian J. Teter, PharmD, BCPP 1.25 pharmacology contact hours
1003-17: Clinical Treatment Targets in Addictions
Contains 5 Component(s), Includes CreditsPresenter: Lorenzo Leggio, MD, PhD, MSc 1.5 pharmacology contact hours
1001-17: The Power of Zzzzs: Sleep Solutions for Psychiatric Nursing Practice
Contains 5 Component(s), Includes CreditsPresenter: Joseph M. Holshoe, MSN, PMHNP-BC 2.0 pharmacology contact hours
APNA Transitions in Practice Certificate Program
Contains 31 Component(s), Includes CreditsThe APNA Transitions in Practice (ATP) Certificate Program has been developed to provide and improve the foundational knowledge of RNs and is presented by recognized expert leaders in the PMH nursing field. The program focuses on best practices and evidence-based nursing knowledge that will optimize success in nursing practice and improve healthcare outcomes for persons with mental health disorders.
are registered in the U.S. Patent and Trademark Office as trademarks of the American Psychiatric Nurses Association.